213 related articles for article (PubMed ID: 37408401)
1. [Pathological significance of plasma cell infiltration in diagnosing lymph node diseases].
Hu H; Jiang YJ; Xu L; Yin LJ; Liu XF; Yin SY; Xu JJ; He MX
Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):702-709. PubMed ID: 37408401
[No Abstract] [Full Text] [Related]
2. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease.
Sato Y; Kojima M; Takata K; Morito T; Asaoku H; Takeuchi T; Mizobuchi K; Fujihara M; Kuraoka K; Nakai T; Ichimura K; Tanaka T; Tamura M; Nishikawa Y; Yoshino T
Mod Pathol; 2009 Apr; 22(4):589-99. PubMed ID: 19270642
[TBL] [Abstract][Full Text] [Related]
3. IgG4-related lymphadenopathy.
Cheuk W; Bledsoe JR
Semin Diagn Pathol; 2024 Mar; 41(2):108-115. PubMed ID: 38228439
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic multicentric castleman's disease mimicking immunoglobulin G4-related disease responding well to Bortezomib: a case report.
Peng Q; Wu F; Shi Y; Wang J; Zhai Z; Wang Z
BMC Nephrol; 2023 Oct; 24(1):290. PubMed ID: 37784011
[TBL] [Abstract][Full Text] [Related]
5. Increased IgG4+ plasma cells are common in excised lymph nodes from children and adolescents without IgG4-related disease.
Whitehair RM; Aguilera NS; Pramoonjago P; Craig JW
J Hematop; 2023 Dec; 16(4):209-216. PubMed ID: 38175435
[TBL] [Abstract][Full Text] [Related]
6. Investigation of IgG4-positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4-related disease.
Nishikori A; Nishimura MF; Nishimura Y; Notohara K; Satou A; Moriyama M; Nakamura S; Sato Y
Pathol Int; 2022 Jan; 72(1):43-52. PubMed ID: 34762752
[TBL] [Abstract][Full Text] [Related]
7. Assessment of pathologically diagnosed patients with Castleman's disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease.
Ogoshi T; Kido T; Yatera K; Oda K; Kawanami T; Ishimoto H; Sakamoto N; Sano A; Yoshii C; Shimajiri S; Mukae H
Lung; 2013 Dec; 191(6):575-83. PubMed ID: 23942842
[TBL] [Abstract][Full Text] [Related]
8. Lymphadenopathy associated with IgG4-related disease: Diagnosis & differential diagnosis.
Wick MR; O'Malley DP
Semin Diagn Pathol; 2018 Jan; 35(1):61-66. PubMed ID: 29157939
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin G4-related disease and idiopathic multicentric Castleman's disease: confusable immune-mediated disorders.
Sasaki T; Akiyama M; Kaneko Y; Takeuchi T
Rheumatology (Oxford); 2022 Feb; 61(2):490-501. PubMed ID: 34363463
[TBL] [Abstract][Full Text] [Related]
10. Rheumatoid lymphadenopathy with abundant IgG4(+) plasma cells : a case mimicking IgG4-related disease.
Asano N; Sato Y
J Clin Exp Hematop; 2012; 52(1):57-61. PubMed ID: 22706532
[TBL] [Abstract][Full Text] [Related]
11. Comparison of IgG4-Related Lymphadenopathy and Multicentric Castleman's Disease: a Retrospective Study.
Sun C; Xu G; Lin J
Clin Lab; 2018 Oct; 64(10):1671-1678. PubMed ID: 30336525
[TBL] [Abstract][Full Text] [Related]
12. IgG4-related Lymphadenopathy: A Comparative Study of 41 Cases Reveals Distinctive Histopathologic Features.
Bledsoe JR; Ferry JA; Neyaz A; Boiocchi L; Strock C; Dresser K; Zukerberg L; Deshpande V
Am J Surg Pathol; 2021 Feb; 45(2):178-192. PubMed ID: 32889888
[TBL] [Abstract][Full Text] [Related]
13. Comparison of plasma cell type of Castleman's disease and IgG4-related sclerosing disease: a histopathological and immunohistochemical study.
Jo JH; Park YS; Jeon YK; Nam SJ; Huh J
Pathobiology; 2011; 78(4):227-32. PubMed ID: 21778790
[TBL] [Abstract][Full Text] [Related]
14. Lymph Nodes With Increased IgG4-positive Plasma Cells and Patterns Suspicious for IgG4-related Disease: Can Lymph Nodes Be the Only Site of Disease?
Chen YR; Yu SC; Wang RC; Lee CL; Song HL; Medeiros LJ; Yue CT; Chang KC
Am J Surg Pathol; 2023 Mar; 47(3):387-396. PubMed ID: 36729678
[TBL] [Abstract][Full Text] [Related]
15. A case of IgG4-related lung disease associated with multicentric Castleman's disease and lung cancer.
Ikari J; Kojima M; Tomita K; Nakamura T; Toyoda F; Otsuki Y; Shimizu S; Kobayashi H; Nakamura H
Intern Med; 2010; 49(13):1287-91. PubMed ID: 20606361
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease.
Terasaki Y; Ikushima S; Matsui S; Hebisawa A; Ichimura Y; Izumi S; Ujita M; Arita M; Tomii K; Komase Y; Owan I; Kawamura T; Matsuzawa Y; Murakami M; Ishimoto H; Kimura H; Bando M; Nishimoto N; Kawabata Y; Fukuda Y; Ogura T;
Histopathology; 2017 Jun; 70(7):1114-1124. PubMed ID: 28207938
[TBL] [Abstract][Full Text] [Related]
17. Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions.
Mochizuki H; Kato M; Higuchi T; Koyamada R; Arai S; Okada S; Eto H
Intern Med; 2017; 56(9):1095-1099. PubMed ID: 28458319
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of a concurrent condition of IgG4-RD and Castleman's disease.
Zhang X; Zhang P; Peng L; Fei Y; Zhang W; Feng R; Zhang W
Clin Rheumatol; 2018 Dec; 37(12):3387-3395. PubMed ID: 29948354
[TBL] [Abstract][Full Text] [Related]
19. Increased IgG4-positive plasma cells in nodular-sclerosing Hodgkin lymphoma: a diagnostic pitfall.
Nowak V; Agaimy A; Kristiansen G; Gütgemann I
Histopathology; 2020 Jan; 76(2):244-250. PubMed ID: 31373020
[TBL] [Abstract][Full Text] [Related]
20. IL-6 expression helps distinguish Castleman's disease from IgG4-related disease in the lung.
Kinugawa Y; Uehara T; Iwaya M; Asaka S; Kobayashi S; Nakajima T; Komatsu M; Yasuo M; Yamamoto H; Ota H
BMC Pulm Med; 2021 Jul; 21(1):219. PubMed ID: 34246246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
